| INTERACTION | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||
| EL0822 | LOC105246506 | Nanog | DNA-TF | regulation | AK141205 is repressed by the transcription factor Nanog. | 20026622 | LncRNADisease | ||
| EL0822 | LOC105246506 | Oct4 and Nanog | RNA-DNA | binding | AK028326 (Oct4-activated) and AK141205 (Nanog-repressed), are direct targets of Oct4 and Nanog. | 20026622 | |||
| EL0822 | LOC105246506 | CXCL13; Nanog | RNA-Protein | regulation | Analysis of CXCL13 expression in SMCs(pcDNA-AK141205) revealed that AK141205 positively promoted CXCL13 expression via acetylation of H4 histone in the promoter region (co-expression); Nanog may directly repress transcription of lncRNA AK141205 (regulation). | 26321662; 20026622 | |||